封面
市場調查報告書
商品編碼
1829312

2025年全球造影超音波市場報告

Contrast Enhanced Ultrasound Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,造影超音波市場規模穩定成長,從2024年的20.5億美元增加到2025年的21.3億美元,複合年成長率為4.1%。預測期內的成長可歸因於診斷準確性和靈敏度的提高、非侵入性和安全性的提高、肝病盛行率的上升、全球人口老化以及對非放射技術的日益偏好。

預計未來幾年,造影超音波市場規模將強勁成長,到2029年將達到26.7億美元,複合年成長率為5.8%。預測期內的成長可歸因於心血管疾病發病率的上升、兒科影像應用的不斷成長、胃腸道影像作用的不斷擴大、對精準醫療的日益關注以及與人工智慧的融合。預測期內的主要趨勢包括持續創新、超音波技術的進步、腫瘤學應用的不斷擴展、與多模態成像的融合、即時定量評估以及兒科應用。

造影造影超音波(CEUS) 是一種醫學成像技術,利用造影劑或微氣泡來提高超音波影像的可見度和清晰度。其應用範圍包括器官內血液灌注成像以及測量心臟和其他身體器官的血流。

造影超音波的關鍵組成部分是設備和造影劑。設備包括用於執行特定任務、操作或功能的實體工具、機器、裝置或儀器。此類設備包括使用造影劑產生即時影像的超音波診斷設備及相關設備。這些技術涵蓋非標靶和標靶方法,可滿足醫院、診所和各種其他應用的需求。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療器材產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療器材重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company)造影報告系列的超音波,該系列提供造影超音波市場統計數據,例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的造影超音波細分市場、市場趨勢和造影造影超音波造影超音波提供您所需的一切資訊,並詳細分析了超音波行業的現狀和未來趨勢。

未來五年的預測成長率為5.8%,較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自瑞典和比利時等主要地區的微氣泡造影劑和諧波成像換能器徵收關稅直接影響美國,從而導致成像品質下降和血管檢查成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛地顯現。

慢性病盛行率的上升預計將顯著推動造影超音波市場的成長。慢性病是需要持續管理和照護的長期疾病,而造影超音波(CEUS) 可提供診斷和監測這些疾病所需的詳細即時影像。例如,世界衛生組織 (WHO) 在 2023 年 9 月報告稱,每年約有 4,100 萬人死於非傳染性疾病 (NCD),佔全球死亡總數的 74%。 CEUS 在這些情況下尤其有用,因為它可以可視化血流和組織灌注,有助於準確評估和管理慢性病。隨著此類疾病的發生率持續上升,對造影超音波等先進診斷影像技術的需求預計將增加,從而進一步推動市場成長。

預計門診手術中心數量的增加將推動造影超音波市場的成長。造影手術中心 (ASC) 專門提供門診手術。這些中心採用超音波(CEUS) 技術,在微創手術過程中提供即時影像導引。根據 VMG Health 預測,到 2022 年,經認證的門診手術中心總數將從 2021 年的 5,906 個增加到 6,028 個。因此,門診手術中心數量的不斷增加預計將推動造影超音波市場的成長。

造影超音波市場由提供診斷影像、治療計畫和監測等服務的營業單位所獲得的收益所構成。市場規模還包括服務提供者銷售或包含在其服務產品中的相關產品的價值。造影超音波市場還包括用於提供全面造影超音波的換能器、注射器、引導工具和影像軟體的銷售。該市場的價值是指“出廠價”,即產品製造商或創造者銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球造影超音波:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 最終用途產業分析
  • 全球造影超音波市場:成長率分析
  • 全球造影超音波市場表現:規模與成長,2019-2024
  • 全球造影超音波市場預測:規模與成長,2024-2029年,2034年
  • 全球造影超音波:總目標市場(TAM)

第6章 市場細分

  • 全球造影超音波市場(按產品、效能和預測),2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 造影
  • 全球造影超音波市場技術、效能及預測(2019-2024、2024-2029、2034)
  • 非目標
  • 目標
  • 全球造影超音波市場的應用、效能和預測,2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 其他
  • 全球造影超音波市場:設備細分、類型、效能及預測(2019-2024 年、2024-2029 年、2034 年)
  • 超音波設備
  • 可攜式超音波設備
  • 全球造影超音波市場:造影造影細分、類型、表現及預測,2019-2024 年、2024-2029 年、2034 年
  • 充氣造影劑
  • 微氣泡造影劑
  • 脂質造影劑

第7章 區域和國家分析

  • 全球造影超音波市場:按地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球造影超音波市場:國家、績效及預測,2019-2024、2024-2029、2034

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 造影超音波市場:競爭格局
  • 造影超音波市場:公司簡介
    • General Electric Company
    • Bayer AG
    • Bristol-Myers Squibb Company
    • Siemens Healthcare GmbH
    • Koninklijke Philips NV

第31章:其他領先和創新企業

  • Daiichi Sankyo Company Limited
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • JB Chemicals and Pharmaceuticals Ltd.
  • Canon Medical Systems
  • Lantheus Medical Imaging Inc.
  • Guerbet
  • Bracco Diagnostic Inc.
  • Esaote SpA
  • Trivitron Healthcare Pvt. Ltd.
  • BK Medical Holding Company Inc.
  • Hitachi Healthcare
  • Chison Medical Technology Co. Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • SuperSonic Imagine SA
  • FUJIFILM Visualsonics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章:市場潛力大的國家與策略

  • 2029 年造影超音波市場:提供新機會的國家
  • 2029 年造影超音波市場:細分市場帶來新機會
  • 2029 年造影超音波市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27782u

Contrast-enhanced ultrasound (CEUS) is a medical imaging technique that employs contrast agents or microbubbles to improve the visibility and clarity of ultrasound images. Its application extends to imaging blood perfusion in organs and measuring blood flow rates in the heart and other bodily organs.

The primary components of contrast-enhanced ultrasound are equipment and contrast agents. Equipment encompasses the physical tools, machinery, devices, or instruments designed to perform specific tasks, operations, or functions. This category includes ultrasound machines and associated devices utilized to generate real-time images using contrast agents. These technologies involve both non-targeted and targeted approaches, catering to the needs of hospitals, clinics, and various other applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The contrast enhanced ultrasound market research report is one of a series of new reports from The Business Research Company that provides contrast enhanced ultrasound market statistics, including the contrast enhanced ultrasound industry global market size, regional shares, competitors with contrast enhanced ultrasound market share, detailed contrast enhanced ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the contrast enhanced ultrasound industry. This contrast enhanced ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The contrast enhanced ultrasound market size has grown steadily in recent years. It will grow from $2.05 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to diagnostic accuracy and sensitivity, non-invasiveness and safety, rising incidence of liver diseases, global increase in aging population, growing preference for non-radiation techniques.

The contrast enhanced ultrasound market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rise in cardiovascular diseases, increasing applications in pediatric imaging, expanding role in gastrointestinal imaging, growing focus on precision medicine, integration with artificial intelligence. Major trends in the forecast period include continued technological innovations, advancements in ultrasound technology, expanding applications in oncology, integration with multimodal imaging, real-time quantitative assessment, pediatric applications.

The forecast of 5.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microbubble contrast agents and harmonic imaging transducers, sourced from key regions such as Sweden and Belgium, which could lead to reduced diagnostic imaging quality and higher costs for vascular studies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is expected to significantly drive the growth of the contrast-enhanced ultrasound market. Chronic diseases are long-term medical conditions that require ongoing management and care, and contrast-enhanced ultrasound (CEUS) provides real-time, detailed imaging crucial for diagnosing and monitoring these conditions. For instance, in September 2023, the World Health Organization reported that approximately 41 million deaths annually, accounting for 74% of all global deaths, are attributed to non-communicable diseases (NCDs), which include many chronic diseases like liver cirrhosis and vascular disorders linked to hypertension. CEUS is particularly valuable in these contexts, as it enhances the visibility of blood flow and tissue perfusion, aiding in the accurate assessment and management of chronic diseases. As the incidence of these conditions continues to rise, the demand for advanced imaging techniques such as contrast-enhanced ultrasound is likely to increase, further propelling market growth.

The increasing number of ambulatory surgical centers is anticipated to contribute to the growth of the contrast-enhanced ultrasound market. Ambulatory Surgery Centers (ASCs) specialize in offering outpatient surgical procedures. Contrast-enhanced ultrasound (CEUS) finds application in these centers to provide real-time image guidance during minimally invasive procedures. In 2022, according to VMG Health, the total number of certified ambulatory surgical centers increased from 5,906 in 2021 to 6,028 centers in 2022. Therefore, the expanding presence of ambulatory surgical centers is expected to drive the contrast-enhanced ultrasound market's growth.

Major companies in the contrast-enhanced ultrasound market are focusing on developing advanced technologies, such as super-resolution contrast-enhanced ultrasound (CEUS) technology, to enhance spatial resolution. The integration of advanced technologies in contrast-enhanced ultrasound improves diagnostic capabilities, providing healthcare professionals with more detailed and accurate information about tissue and organ anatomy, function, and perfusion. In September 2023, Philips launched the Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS), utilizing advanced signal processing algorithms to enhance spatial resolution. This technology provides high-resolution images for diagnosing and treating various diseases, including cancer, liver disease, and vascular diseases.

In July 2024, GE HealthCare Technologies Inc., a US-based medical technology company, announced its acquisition of Intelligent Ultrasound Group PLC for an undisclosed amount. This strategic acquisition aims to integrate Intelligent Ultrasound's advanced solutions into GE HealthCare's existing ultrasound portfolio, enhancing both the efficiency and intelligence of their ultrasound offerings. The integration of these AI-driven technologies is expected to significantly improve the accuracy and usability of ultrasound systems, addressing the increasing demand for smarter imaging solutions within the healthcare industry. Intelligent Ultrasound Group PLC, based in the UK, specializes in innovative ultrasound systems, particularly focusing on applications related to contrast-enhanced ultrasound. This acquisition aligns with GE HealthCare's commitment to advancing imaging technologies and improving patient care through enhanced diagnostic capabilities.

Major companies operating in the contrast enhanced ultrasound market report are General Electric Company, Bayer AG, Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Koninklijke Philips N.V., Daiichi Sankyo Company Limited, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., J.B. Chemicals and Pharmaceuticals Ltd., Canon Medical Systems, Lantheus Medical Imaging Inc., Guerbet, Bracco Diagnostic Inc., Esaote S.p.A., Trivitron Healthcare Pvt. Ltd., BK Medical Holding Company Inc., Hitachi Healthcare, Chison Medical Technology Co. Ltd., SANOCHEMIA Pharmazeutika GmbH, SuperSonic Imagine SA, FUJIFILM Visualsonics Inc., Leriva Pharma SA, Samsung Healthcare, Jodas Expoim Pvt Ltd., nanoPET Pharma GmbH, Alpinion Medical Systems, Acusphere Inc., ContextVision AB, Teratech Corporation, Solstice Pharmaceuticals B.V.

North America was the largest region in the contrast-enhanced ultrasound market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contrast enhanced ultrasound market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the contrast-enhanced ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contrast-enhanced ultrasound market consists of revenues earned by entities by providing services such as diagnostic imaging services, treatment planning services, and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The contrast-enhanced ultrasound market also includes sales of transducers, injectors, guidance tools, and imaging software that are used in providing comprehensive contrast-enhanced ultrasound. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contrast Enhanced Ultrasound Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contrast enhanced ultrasound market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contrast enhanced ultrasound ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contrast enhanced ultrasound market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Equipment; Contrast Agent
  • 2) By Technology: Non-targeted; Targeted
  • 3) By Application: Hospitals; Clinics; Other Applications
  • Subsegments:
  • 1) By Equipment: Ultrasound Machines; Portable Ultrasound Devices
  • 2) By Contrast Agent: Gas-filled Contrast Agents; Microbubble Contrast Agents; Lipid-based Contrast Agents
  • Companies Mentioned: General Electric Company; Bayer AG; Bristol-Myers Squibb Company; Siemens Healthcare GmbH; Koninklijke Philips N.V.; Daiichi Sankyo Company Limited; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; J.B. Chemicals and Pharmaceuticals Ltd.; Canon Medical Systems; Lantheus Medical Imaging Inc.; Guerbet; Bracco Diagnostic Inc.; Esaote S.p.A.; Trivitron Healthcare Pvt. Ltd.; BK Medical Holding Company Inc.; Hitachi Healthcare; Chison Medical Technology Co. Ltd.; SANOCHEMIA Pharmazeutika GmbH; SuperSonic Imagine SA; FUJIFILM Visualsonics Inc.; Leriva Pharma SA; Samsung Healthcare; Jodas Expoim Pvt Ltd.; nanoPET Pharma GmbH; Alpinion Medical Systems; Acusphere Inc.; ContextVision AB; Teratech Corporation; Solstice Pharmaceuticals B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contrast Enhanced Ultrasound Market Characteristics

3. Contrast Enhanced Ultrasound Market Trends And Strategies

4. Contrast Enhanced Ultrasound Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Contrast Enhanced Ultrasound Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Contrast Enhanced Ultrasound PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Contrast Enhanced Ultrasound Market Growth Rate Analysis
  • 5.4. Global Contrast Enhanced Ultrasound Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Contrast Enhanced Ultrasound Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Contrast Enhanced Ultrasound Total Addressable Market (TAM)

6. Contrast Enhanced Ultrasound Market Segmentation

  • 6.1. Global Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Equipment
  • Contrast Agent
  • 6.2. Global Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-targeted
  • Targeted
  • 6.3. Global Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other Applications
  • 6.4. Global Contrast Enhanced Ultrasound Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound Machines
  • Portable Ultrasound Devices
  • 6.5. Global Contrast Enhanced Ultrasound Market, Sub-Segmentation Of Contrast Agent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gas-filled Contrast Agents
  • Microbubble Contrast Agents
  • Lipid-based Contrast Agents

7. Contrast Enhanced Ultrasound Market Regional And Country Analysis

  • 7.1. Global Contrast Enhanced Ultrasound Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Contrast Enhanced Ultrasound Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contrast Enhanced Ultrasound Market

  • 8.1. Asia-Pacific Contrast Enhanced Ultrasound Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contrast Enhanced Ultrasound Market

  • 9.1. China Contrast Enhanced Ultrasound Market Overview
  • 9.2. China Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contrast Enhanced Ultrasound Market

  • 10.1. India Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contrast Enhanced Ultrasound Market

  • 11.1. Japan Contrast Enhanced Ultrasound Market Overview
  • 11.2. Japan Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contrast Enhanced Ultrasound Market

  • 12.1. Australia Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contrast Enhanced Ultrasound Market

  • 13.1. Indonesia Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contrast Enhanced Ultrasound Market

  • 14.1. South Korea Contrast Enhanced Ultrasound Market Overview
  • 14.2. South Korea Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contrast Enhanced Ultrasound Market

  • 15.1. Western Europe Contrast Enhanced Ultrasound Market Overview
  • 15.2. Western Europe Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contrast Enhanced Ultrasound Market

  • 16.1. UK Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contrast Enhanced Ultrasound Market

  • 17.1. Germany Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contrast Enhanced Ultrasound Market

  • 18.1. France Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contrast Enhanced Ultrasound Market

  • 19.1. Italy Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contrast Enhanced Ultrasound Market

  • 20.1. Spain Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contrast Enhanced Ultrasound Market

  • 21.1. Eastern Europe Contrast Enhanced Ultrasound Market Overview
  • 21.2. Eastern Europe Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contrast Enhanced Ultrasound Market

  • 22.1. Russia Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contrast Enhanced Ultrasound Market

  • 23.1. North America Contrast Enhanced Ultrasound Market Overview
  • 23.2. North America Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contrast Enhanced Ultrasound Market

  • 24.1. USA Contrast Enhanced Ultrasound Market Overview
  • 24.2. USA Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contrast Enhanced Ultrasound Market

  • 25.1. Canada Contrast Enhanced Ultrasound Market Overview
  • 25.2. Canada Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contrast Enhanced Ultrasound Market

  • 26.1. South America Contrast Enhanced Ultrasound Market Overview
  • 26.2. South America Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contrast Enhanced Ultrasound Market

  • 27.1. Brazil Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contrast Enhanced Ultrasound Market

  • 28.1. Middle East Contrast Enhanced Ultrasound Market Overview
  • 28.2. Middle East Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contrast Enhanced Ultrasound Market

  • 29.1. Africa Contrast Enhanced Ultrasound Market Overview
  • 29.2. Africa Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contrast Enhanced Ultrasound Market Competitive Landscape And Company Profiles

  • 30.1. Contrast Enhanced Ultrasound Market Competitive Landscape
  • 30.2. Contrast Enhanced Ultrasound Market Company Profiles
    • 30.2.1. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Contrast Enhanced Ultrasound Market Other Major And Innovative Companies

  • 31.1. Daiichi Sankyo Company Limited
  • 31.2. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.3. J.B. Chemicals and Pharmaceuticals Ltd.
  • 31.4. Canon Medical Systems
  • 31.5. Lantheus Medical Imaging Inc.
  • 31.6. Guerbet
  • 31.7. Bracco Diagnostic Inc.
  • 31.8. Esaote S.p.A.
  • 31.9. Trivitron Healthcare Pvt. Ltd.
  • 31.10. BK Medical Holding Company Inc.
  • 31.11. Hitachi Healthcare
  • 31.12. Chison Medical Technology Co. Ltd.
  • 31.13. SANOCHEMIA Pharmazeutika GmbH
  • 31.14. SuperSonic Imagine SA
  • 31.15. FUJIFILM Visualsonics Inc.

32. Global Contrast Enhanced Ultrasound Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contrast Enhanced Ultrasound Market

34. Recent Developments In The Contrast Enhanced Ultrasound Market

35. Contrast Enhanced Ultrasound Market High Potential Countries, Segments and Strategies

  • 35.1 Contrast Enhanced Ultrasound Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Contrast Enhanced Ultrasound Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Contrast Enhanced Ultrasound Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer